Testicular cancer

L Cheng, P Albers, DM Berney, DR Feldman… - Nature Reviews …, 2018 - nature.com
Testicular cancer is the most common malignancy among men between 14 and 44 years of
age, and its incidence has risen over the past two decades in Western countries. Both …

Testicular germ cell tumours

E Rajpert-De Meyts, KA McGlynn, K Okamoto… - The Lancet, 2016 - thelancet.com
Testicular germ cell tumours are at the crossroads of developmental and neoplastic
processes. Their cause has not been fully elucidated but differences in incidences suggest …

Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up☆

J Oldenburg, DM Berney, C Bokemeyer… - Annals of …, 2022 - annalsofoncology.org
Germ-cell tumours (GCTs) affect predominantly younger males aged between 15 and 40
years, with nearly 74 500 new cases estimated globally in 2020. 1 About one-third of all GCT …

[HTML][HTML] ESMO Consensus Conference on testicular germ cell cancer: diagnosis, treatment and follow-up

F Honecker, J Aparicio, D Berney, J Beyer… - Annals of oncology, 2018 - Elsevier
Abstract The European Society for Medical Oncology (ESMO) consensus conference on
testicular cancer was held on 3–5 November 2016 in Paris, France. The conference …

Guidelines on testicular cancer: 2015 update

P Albers, W Albrecht, F Algaba, C Bokemeyer… - European urology, 2015 - Elsevier
Context This is an update of the previous European Association of Urology testis cancer
guidelines published in 2011, which included major changes in the diagnosis and treatment …

[HTML][HTML] Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

J Oldenburg, SD Fosså, J Nuver, A Heidenreich… - Annals of …, 2013 - Elsevier
Germ cell tumours (GCT) represent a rare malignancy affecting mostly Caucasian males
aged between 15 and 40 years. Among these young men, testicular GCT (TGCT) is the most …

EAU guidelines on testicular cancer: 2011 update

P Albers, W Albrecht, F Algaba, C Bokemeyer… - European urology, 2011 - Elsevier
Context On behalf of the European Association of Urology (EAU), guidelines for the
diagnosis, therapy, and follow-up of testicular cancer were established. Objective This article …

[HTML][HTML] Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and …

J Beyer, P Albers, R Altena, J Aparicio, C Bokemeyer… - Annals of oncology, 2013 - Elsevier
Abstract In November 2011, the Third European Consensus Conference on Diagnosis and
Treatment of Germ-Cell Cancer (GCC) was held in Berlin, Germany. This third conference …

Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial

K Fizazi, L Pagliaro, A Laplanche, A Fléchon… - The Lancet …, 2014 - thelancet.com
Background Poor prognosis germ-cell tumours are only cured in about half of patients. We
aimed to assess whether treatment intensification based on an early tumour marker decline …

Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international …

A Lorch, C Bascoul-Mollevi, A Kramar… - Journal of clinical …, 2011 - ascopubs.org
Purpose Conventional-dose chemotherapy (CDCT) and high-dose chemotherapy (HDCT)
may both be successfully used as salvage treatment for patients with metastatic germ cell …